Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 20;5(1):240-274.
doi: 10.20411/pai.v5i1.382. eCollection 2020.

Novel Strategies to Combat CMV-Related Cardiovascular Disease

Elena Vasilieva  1 , Sara Gianella  2 , Michael L Freeman  3
Affiliations
Review

Novel Strategies to Combat CMV-Related Cardiovascular Disease

Elena Vasilieva et al. Pathog Immun. .

Abstract

Cytomegalovirus (CMV), a ubiquitous human pathogen that is never cleared from the host, has long been thought to be relatively innocuous in immunocompetent adults, but causes severe complications including blindness, end-organ disease, and death in newborns and in immuno-compromised individuals, such as organ transplant recipients and those suffering from AIDS. Yet even in persons with intact immunity, CMV infection is associated with profound stimulation of immune and inflammatory pathways. Carriers of CMV infection also have an elevated risk of developing cardiovascular complications. In this review, we define the proposed mechanisms of how CMV contributes to cardiovascular disease (CVD), describe current approaches to target CMV, and discuss how these strategies may or may not alleviate cardiovascular complications in those with CMV infection. In addition, we discuss the special situation of CMV coinfection in people with HIV infection receiving antiretroviral therapy, and describe how these 2 viral infections may interact to potentiate CVD in this especially vulnerable population.

Keywords: Antivirals; Atherosclerosis; Cardiovascular Disease (CVD); Cytomegalovirus (CMV); Human Immunodeficiency Virus (HIV); Immunotherapy; Inflammation; Vaccines.

PubMed Disclaimer

Conflict of interest statement

The authors declare that no financial conflicts of interest exist for this work.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ.. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006;43(9):1143-51. Epub 2006/10/10. doi: 10.1086/508173. PubMed PMID: 17029132. - DOI - PubMed
    1. Bate SL, Dollard SC, Cannon MJ.. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010;50(11):1439-47. Epub 2010/04/30. doi: 10.1086/652438. PubMed PMID: 20426575. - DOI - PMC - PubMed
    1. Griffiths PD, Baboonian C.. A prospective study of primary cytomegalovirus infection during pregnancy: final report. Br J Obstet Gynaecol. 1984;91(4):307-15. Epub 1984/04/01. doi: 10.1111/j.1471-0528.1984.tb05915.x. PubMed PMID: 6324849. - DOI - PubMed
    1. Tookey PA, Ades AE, Peckham CS.. Cytomegalovirus prevalence in pregnant women: the influence of parity. Arch Dis Child. 1992;67(7 Spec No):779-83. Epub 1992/07/01. doi: 10.1136/adc.67.7_spec_no.779. PubMed PMID: 1325757; PMCID: PMC1590405. - DOI - PMC - PubMed
    1. Bates M, Brantsaeter AB.. Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen. J Virus Erad. 2016;2(3):136-42. Epub 2016/08/03. PubMed PMID: 27482452; PMCID: PMC4967964. - PMC - PubMed

LinkOut - more resources